cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Swk Holdings Corp
1 watching
Current Price
$0
$0.03
(0.16%)
logo-swkh
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
242.07M
52-Week High
52-Week High
19.99
52-Week Low
52-Week Low
16.0601
Average Volume
Average Volume
0M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
9.0951
iconMarket Capitalization242.07M
icon52-Week High19.99
icon52-Week Low16.0601
iconAverage Volume0M
iconDividend Yield--
iconP/E Ratio9.0951
What does the Swk Holdings Corp do?
SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Its product pipeline includes Ovarest, an oral leuprolide tablet to treat endocrine disease. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.
Read More
How much money does Swk Holdings Corp make?
News & Events about Swk Holdings Corp.
PR Newswire
29days ago
SWK Holdings Names Jody Staggs Chief Executive Officer and Appoints Laurie Dotter as Chair of the Board SWK Holdings Names Jody Staggs Chief Executive Officer and Appoints Laurie Dotter as Chair of the Board PR Newswire DALLAS, Jan. 3, 2023 Mr. Staggs elevated from 'interim' to...
PR Newswire
6 months ago
Enteris BioPharma Manufacturing Expertise Highlighted in Drug Development & Delivery Special Feature on Outsourcing Formulation Development & Manufacturing Enteris BioPharma Manufacturing Expertise Highlighted in Drug Development & Delivery Special Feature on Outsourcing...
PR Newswire
7 months ago
Enteris BioPharma Presents Data from Two Clinical Studies Involving Oral Formulations of Leuprolide at ENDO 2022 Annual Conference Enteris BioPharma Presents Data from Two Clinical Studies Involving Oral Formulations of Leuprolide at ENDO 2022 Annual Conference PR Newswire BOONTON, N.J., June 13...
PR Newswire
8 months ago
Enteris Employees Lend Ronald McDonald House a Helping Hand at Enteris Day 2022 Enteris Employees Lend Ronald McDonald House a Helping Hand at Enteris Day 2022 PR Newswire BOONTON, N.J., May 26, 2022 BOONTON, N.J., May 26, 2022 /PRNewswire/ -- Enteris BioPharma, Inc.gave plush animals a dose of...
Frequently Asked Questions
Frequently Asked Questions
What is Swk Holdings Corp share price today?
plus_minus_icon
Can Indians buy Swk Holdings Corp shares?
plus_minus_icon
How can I buy Swk Holdings Corp shares from India?
plus_minus_icon
Can Fractional shares of Swk Holdings Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Swk Holdings Corp stocks?
plus_minus_icon
What is today’s traded volume of Swk Holdings Corp?
plus_minus_icon
What is today’s market capitalisation of Swk Holdings Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Swk Holdings Corp?
plus_minus_icon
What percentage is Swk Holdings Corp down from its 52-Week High?
plus_minus_icon
What percentage is Swk Holdings Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.03
(0.16%)
logo-swkh
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00